MaxCyte’s high-performance delivery platform enables previously unfeasible cell-engineering applications.

Our cell-engineering platform harnesses the power of the cell to accelerate the development of small molecule drugs, biologics, vaccines and cell and gene therapies to address a wide array of acute and chronic disease indications.

Our high-performance delivery platform does not require the use of specific cell types, expression vectors, media additives or reagents, providing scientists with the freedom to use the most relevant system for their application and facilitates the rapid identification, development, and manufacturing of higher quality candidates.

The high transfection efficiencies and cell health post electroporation using our delivery platform lead to excellent performance of engineered cells in downstream applications.



Functional cell-based assay

Protein and antibody expression

Stable cell line development

Viral vector production

Gene editing

Cell and gene therapies

Resource Center

Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter

Request Demo